Advanced Flower Capital Inc. Faces Substantial Earnings Misses in 2025
Advanced Flower Capital Inc. (NASDAQ: AFCG), the cannabis‑industry finance specialist that structures and underwrites senior secured loans, reported its fourth‑quarter and full‑year 2025 results on March 4, 2026. The company’s financial performance fell short of market expectations on both revenue and earnings per share, raising concerns about the sustainability of its growth model.
Earnings Miss and Revenue Shortfall
According to the company’s earnings release, the non‑GAAP earnings per share for Q4 2025 came in at ‑$0.12—a miss of $0.06 compared with analyst consensus. Meanwhile, revenue of $5.19 million fell short by $0.2 million. The preview reports on Benzinga and Seeking Alpha suggested that the company’s guidance for the quarter would be uneven at best, and investors were already braced for a disappointment.
Historical Context
The negative earnings trend is not an isolated incident. In the previous fiscal year, Advanced Flower Capital posted a non‑GAAP earnings loss of $0.78 per share and a revenue of $25.0 million, compared with the previous year’s $0.54 per share profit and $51.9 million revenue. Analysts from finanzen.net projected a modest improvement to $0.013 per share in Q4 2025, but even that figure is a sharp decline from the $0.050 loss recorded in the same quarter a year earlier. The company’s 2025 revenue is expected to shrink by almost 40 % relative to the 2024 quarter, echoing the broader contraction seen across its peer group.
Market Reaction
The stock has traded near $2.21 on March 2, 2026, a steep drop from its 52‑week high of $8.55 in March 2025. Analysts have cautioned that the company’s price‑to‑earnings ratio of -2.19 signals a lack of profitability and a potential tax exposure, despite its real‑estate investment trust (REIT) status that normally shields it from federal corporate income tax when distributing at least 90 % of taxable income to shareholders. The market’s negative sentiment is further reflected in the broader earnings calendar, where Advanced Flower Capital is listed among the stocks that slipped on March 4, 2026.
Forward‑Looking Concerns
Advanced Flower Capital’s business model—originating loans secured by real estate, equipment, and cannabis‑industry licenses—requires a healthy pipeline of borrowers and favorable regulatory conditions. The recent earnings miss indicates that the company may be struggling to maintain sufficient underwriting volume or to achieve the expected recovery rates on its loan portfolio. Moreover, the company’s relatively low market capitalization of $49.9 million limits its capacity to weather prolonged periods of negative earnings.
Conclusion
Advanced Flower Capital Inc.’s latest financial disclosure underscores a significant downturn in profitability and revenue. With a history of earnings volatility and a shrinking top line, the company faces mounting pressure from investors and analysts alike. Whether the firm can reverse this trend will hinge on its ability to secure new loan origination, manage credit risk, and navigate the complex regulatory landscape of the cannabis industry.
